Etubics Overview

  • Founded
  • 2003
  • Status
  • Acquired/​Merged
  • Employees
  • 14
  • Latest Deal Type
  • M&A

Etubics General Information


Operator of a clinical stage bio-pharmaceutical platform designed to develop targeted immunotherapies and vaccine products. The company's clinical stage bio-pharmaceutical platform develops innovative immunotherapies and vaccines utilizing next-generation viral vector gene delivery technology and their patented manufacturing cell line, enabling physicians treat patients with a wide range of resilient diseases more effective than current vectored vaccines and gene delivery platforms.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 410 West Harrison Street
  • Suite 200
  • Seattle, WA 98119
  • United States
+1 (206) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Etubics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Jan-2016 0000 Completed Generating Revenue
6. Later Stage VC 01-Oct-2015 0000 0000 Completed Generating Revenue
5. Grant 30-Apr-2014 00.00 Completed Generating Revenue
4. Grant 26-Sep-2013 00.000 Completed Generating Revenue
3. Grant 05-Jul-2011 00000 Completed Generating Revenue
2. Grant 23-Aug-2007 $600K Completed Startup
1. Early Stage VC Completed Startup
To view Etubics’s complete valuation and funding history, request access »

Etubics Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Operator of a clinical stage bio-pharmaceutical platform designed to develop targeted immunotherapies and vaccine produc
Other Devices and Supplies
Seattle, WA
14 As of 2016
000000&0 0000


is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
0000 000000000
Farmington, CT
0 As of 0000
0000000000 00.000


fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
Lexington, MA
000 As of 0000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Etubics Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CaroGen Venture Capital-Backed Farmington, CT 0 00.000 0000000000 00.000
000000 Formerly VC-backed Lexington, MA 000 00000 000000000 00000
0000000000 0000 00 Corporation New Haven, CT
00000000000 Formerly VC-backed Louisville, CO 0 00000 000000&0 00000
00000 Formerly VC-backed Cambridge, MA 000 00000 000000&0
You’re viewing 5 of 12 competitors. Get the full list »

Etubics Executive Team (7)

Name Title Board Seat Contact Info
Frank Jones Founder, President, Chairman & Chief Scientific Officer
Joseph Balint Ph.D Senior Scientist
Carol Jones Vice President, Administration
Kate Gonsalves Senior Director, Operations & Strategic Initiatives
You’re viewing 4 of 7 executive team members. Get the full list »

Etubics Board Members (10)

Name Representing Role Since
Charles Kim Etubics Board Member 000 0000
Francis Barton Self Board Member 000 0000
Gilbert Omenn Ph.D Self Board Member 000 0000
Jerome Zeldis Ph.D Self Board Member 000 0000
John Abeles MD Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Etubics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Etubics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Intuitive Venture Partners Investment Bank Minority 000 0000 000000 0
Kevin D'Silva Angel (individual) Minority 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view Etubics’s complete investors history, request access »